Deprescribing is the medically supervised tapering or cessation of medications that are no longer needed or beneficial, including medications that are potentially inappropriate (PIMs), time delimited, ineffective, or that do not align with goals of care.
1 After an acute care hospitalization, adverse drug events (ADEs) are common and up to 60% are considered preventable.
2 Deprescribing PIMs at hospital discharge to prevent ADEs could be advantageous; however, several barriers exist.
3,4 First, hospital practitioners focused on acute care requirements may be reluctant to alter long-term outpatient therapies managed by other prescribers, particularly if they do not follow patients postdischarge.
5 Second, not all centers include routine pharmacist or geriatrician subspecialties to support interprofessional care. Third, some prescribers fear that stopping or reducing a drug can lead to adverse effects.
6 Fourth, despite deprescribing opportunities, therapeutic inertia is common
7,8; true even for low-risk drugs with no withdrawal concerns
9 and more so for drugs with higher risks of harm.
10 Even when adverse events occur, opportunities to deprescribe are not always recognized or acted on.
11,12 To our knowledge, prior studies of interventions to reduce PIMs while in hospital
13-15 have tended to be underpowered and nonrandomized or did not capture postdischarge ADEs.